Market Place
Sourcing Support
Waverley`s Generic Bortezomib Receives Approval in the U.S.
11 Oct 2022 //
FDA
Waverley Pharma Generic Pemetrexed Receives Approval in the U.S.
25 May 2022 //
FDA
Waverley Pharma Announces Successful Tender Award for Pemetrexed with NHS
27 May 2021 //
NEWSWIRE
Waverley Pharma Announces Successful Tender Award for Capecitabine with NHS
18 Jan 2021 //
NEWSWIRE
Waverley Pharma to Acquire Rights to Market Six Generic Oncology Products
09 Sep 2020 //
NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.